Natco Pharma Ltd 524816
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹821.50
- Day Range
- ₹807.45–831.00
- 52-Week Range
- ₹774.00–1,226.10
- Bid/Ask
- ₹0.00 / ₹0.00
- Shares Outstanding
- 196.17M
- Market Cap
- ₹160.27B
- Volume/Avg
- 63,286 / 52,556
Key Statistics
- Price/Earnings (Normalized)
- 18.04
- Price/Sales
- 4.80
- Dividend Yield (Trailing)
- 0.70%
- Dividend Yield (Forward)
- 0.70%
- Dividend Payment Schedule
- Feb, Aug, Nov
- Total Yield
- 0.70%
Company Profile
Natco Pharma Ltd is engaged in the development, manufacturing, and marketing of Finished Dosage Formulations (FDFs), Active Pharmaceutical Ingredients (APIs), and Agrochemicals. The Group's API business develops cGMP-compliant drug substances, with oncology as its core therapeutic area, along with CNS, pain management, and cardiovascular care. The FDFs portfolio comprises products across neurology, oncology, hepatology, infectious diseases, cardiology, and other areas, and the Agrochemicals business offers insecticides, fungicides, plant growth promoters, herbicides, and other related products. Its reportable segments are Pharmaceuticals, which derives key revenue, and Agro Chemicals. Geographically, the Group derives maximum revenue from the USA, and the rest from India and other markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,060
Valuation
Metric | 524816 |
|---|---|
Price/Earnings (Normalized) | 18.04 |
Price/Book Value | 1.66 |
Price/Sales | 4.80 |
Price/Cash Flow | 29.44 |
Price/Earnings
524816
Financial Strength
Metric | 524816 |
|---|---|
Quick Ratio | 1.43 |
Current Ratio | 2.17 |
Interest Coverage | 15.39 |
Quick Ratio
524816
Profitability
Metric | 524816 |
|---|---|
Return on Assets (Normalized) | 7.43% |
Return on Equity (Normalized) | 8.96% |
Return on Invested Capital (Normalized) | 8.82% |
Return on Assets
524816
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|>nTvW<W< | LOCK|?@d&? | $71B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|%&pPz<L | LOCK|zZsx | $47B | |||
| Haleon PLC ADR HLN | LOCK|?<DjL$ | LOCK|^$$ | $39B | |||
| Zoetis Inc Class A ZTS | LOCK|Ln#VN!j | LOCK|jM< | $33B | |||
| Viatris Inc VTRS | LOCK|kwC$%Pj | LOCK|!%B | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|J$r | LOCK|%# | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|F^z<h$$ | LOCK|L# | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|V%GFT^v | LOCK|grD | $4B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|%CT>l?b | LOCK|T@s% | $2B | |||
| Perrigo Co PLC PRGO | LOCK|xFm><^ | LOCK|vr | $2B |